Laurion Capital Management LP Oric Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $32,238 - $84,415	11,940 New	11,940 $53,000
Q1 2022 May 16, 2022	SELL	$4.54 - $16.1 $217,107 - $769,918	-47,821 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.9 - $25.22 $209,164 - $331,769	-13,155 Reduced 21.57%	47,821 $1 Million
Q2 2021 Aug 13, 2021	SELL	$17.37 - $25.34 $278,336 - $406,048	-16,024 Reduced 20.81%	60,976 $1.08 Million
Q1 2021 May 14, 2021	SELL	$23.67 - $36.85 $462,417 - $719,901	-19,536 Reduced 20.24%	77,000 $1.89 Million
Q4 2020 Feb 12, 2021	BUY	$20.32 - $39.8 $396,971 - $777,532	19,536 Added 25.37%	96,536 $3.27 Million
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $1.98 Million - $2.94 Million	77,000 New	77,000 $2.6 Million

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.